Hager Jeffrey 4
4 · IDEAYA Biosciences, Inc. · Filed Jul 30, 2019
Insider Transaction Report
Form 4
Hager Jeffrey
SVP, Chief Technology Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-07-26−5,197→ 10,396 totalExercise: $4.31Exp: 2028-04-12→ Common Stock (5,197 underlying) - Exercise/Conversion
Common Stock
2019-07-26$4.31/sh+5,197$22,399→ 127,853 total
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.